Hydrazine Sulphate

Hydrazine Sulphate

Hydrazine sulfate (or sulfate, in US spelling) is a commonly used, inexpensive industrial compound. Biologically, it inhibits a particular liver and kidney enzyme (a monoamine oxidase or MAO), thereby preventing cancer cells from obtaining glucose. This has been shown to inhibit cachexia (wasting), which is the immediate cause of death in over 70% of cancer cases. In a smaller number of cases, there is also some tumor regression. This enables some patients to overcome their cancer or live with it. This has been demonstrated in several clinical trials.

Research began in 1968 with an article suggesting that cachexia could be reduced by targeting a particular liver and kidney enzyme. Dr Joseph Gold of the Syracuse Cancer Research Institute of New York, who has pioneered the use of hydrazine sulfate as a cancer treatment, began testing rodents with hydrazine sulfate, getting rapid and positive results. The compound was then tested on human beings, with mixed results.

Like most cancer treatments, mainstream or complementary, hydrazine sulfate does not always work. There is also a long list of foods with which it interacts badly, and it should only be taken under medical supervision. Like other MAO inhibitors, it is incompatible with barbiturates, tranquilizers, alcohol, and other depressants of the central nervous system. Foods high in the amino acid, tyramine, such as mature cheeses and fermented foods should also be avoided.

Hydrazine sulfate has been the focus of considerable controversy in the cancer industry. Mainstream organizations refer to trials sponsored by the National Cancer Institute in the mid-1990s, which showed no benefit from its use. Critics have observed that these trials did not follow the correct procedures, since 94% of the patients were given tranquilizers, and were permitted the use of alcohol and barbiturates.

Annie Appleseed Project – An excellent introduction and overview, with some details of dosage, and which foods to avoid.

Diagnose Me – A useful overview.

Day Industries – Hydrazine Sulfate: The Real Story. A narrative overview.

Syracuse Cancer Research Institute – The charitable organization where Dr Joseph Gold works.

The Truth about Hydrazine Sulfate – Dr Joseph Gold tells his side of the story.

National Cancer Institute – A summary of hydrazine sulphate trials and other information from the viewpoint of the NCI.

National Institute of Health – A summary of the events in the political and trial history of hydrazine sulphate.

The Moss Reports – A review of trial data from before the publication of results from the NCI-sponsored trials.

Dr Burton Goldberg – “Holding the National Cancer Institute Accountable for Cancer Deaths.” An overview of some of the politics surrounding hydrazine sulphate.

Nu-gen Nutrition – A source of hydrazine sulphate from a US supplier of complementary cancer treatments.

Caesium Chloride– High pH Therapy

Caesium or cesium (US spelling) chloride is associated with the high pH (alkalinizing) therapeutic approach to cancer treatment. The theory that cancer cells are more susceptible than normal cells to high pH originated with the observation that certain areas of the world with a lower risk of cancer also had a higher soil concentration of alkali metals (especially potassium, cesium, and rubidium).

Researchers back in the 1920s first suggested cesium might be a useful anti-tumor agent. However, further studies in the 1930s showed no evidence for this. The high pH therapy for cancer was first advanced during the 1980s by Keith Brewer PhD, who published numerous papers and articles concerning the treatment, together with suggestions for further research. Dr Brewer was a physicist who felt that many of the findings of physics were relevant to biology, especially the physics of the cell membrane. He arrived at his therapeutic approach after considerable experimentation on cell membranes. Animal research studies confirming his theory, funded by Dr Brewer, were undertaken by Dr Marilyn Tufte of the Department of Biology at the University of Wisconsin at Platteville. A small number of uncontrolled human trials conducted by various physicians, especially Dr H.A. Nieper in Hannover, Germany, and Dr H.E. Sartori in Washington, DC, also showed significant positive results. As well as loss of pain within 12 to 24 hours, the treatment also resulted in rapid shrinkage of the tumor mass. However, Nieper and Sartori were also using vitamin B17, which in itself is regarded as a significant cancer treatment, so their results are not conclusive.

High pH therapy using caesium chloride therapy is usually given to patients with advanced metastatic cancer, for whom standard medicine can do no more. However, due to lack of sufficient research, there is no agreed dosage or treatment protocol. Generally, up to 6 to 9 gms per day (or sometimes more) of caesium chloride is administered in liquid form along with vitamins A and C, together with zinc and selenium supplements, which enhance the cellular uptake of caesium. Keith Brewer observes that there is some evidence …